Literature DB >> 8612662

Technetium-99m labelled hydrazinonicotinamido human non-specific polyclonal immunoglobulin G for detection of infectious foci: a comparison with two other technetium-labelled immunoglobulin preparations.

R A Claessens1, O C Boerman, E B Koenders, W J Oyen, J W van der Meer, F H Corstens.   

Abstract

Recently a new linker - hydrazinonicotinate (HYNIC) - was introduced for labelling of proteins and peptides with technetium-99m. HYNIC and other linkers have been used for labelling of human non-specific polyclonal immunoglobulin G (hIgG) with 99mTc for the detection of infections. In this study we compared the tissue distribution of three different 99mTc-hIgG preparations in groups of five Wistar rats with a focal intramuscular infection with Staphylococcus aureus. We compared 99mTc-HYNIC-hIgG with 99mTc-hIgG labelled via the so-called Schwarz method (reduction of disulphide bonds) and with the 99mTc-labelled commercially available Technescan-HIG. Unlike the HYNIC linker, in the two other labelling methods free sulph-hydryl groups are involved in the binding of 99mTc. High-performance liquid chromatography analysis of the labelled preparations and of plasma samples revealed aggregate or polymer formation in all three agents; this was least pronounced in the product labelled by means of the Schwarz method. The tested preparations did not show signs of degradation in vitro. The difference in linker chemistry was reflected in the tissue distribution. Thus the biodistribution of 99mTc-HYNIC-hIgG was significantly different from the distribution of the two other preparations: abscess (1.4%+/-0.2%ID/g), muscle, liver, spleen, plasma, lung, bone marrow, and small intestine concentrations were higher at 24 h p.i.; kidney uptake (1.19%+/-0.08%ID/g) was significantly lower. The abscess-to-plasma and the abscess-to-muscle ratios (0.5 and 11, respectively), however, were in the same range for the three preparations tested. Quantitative analysis of the scintigraphs revealed that the total body clearance of 99mTc-HYNIC-hIgG was significantly slower than for the other agents. The abscess uptake of 99mTc-HYNIC-hIgG as a percentage of the remaining body activity was significantly higher. Based on its high abscess uptake, its low uptake in the kidneys and the high percentage of its abscess uptake in relation to the remaining body activity, we conclude that 99mTc-HYNIC-hIgG seems superior to the two other preparations tested for the detection of infections.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612662     DOI: 10.1007/bf01247370

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  17 in total

1.  Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats.

Authors:  M J Abrams; M Juweid; C I tenKate; D A Schwartz; M M Hauser; F E Gaul; A J Fuccello; R H Rubin; H W Strauss; A J Fischman
Journal:  J Nucl Med       Date:  1990-12       Impact factor: 10.057

2.  Diagnosing infection in febrile granulocytopenic patients with indium-111-labeled human immunoglobulin G.

Authors:  W J Oyen; R A Claessens; J M Raemaekers; B E de Pauw; J W van der Meer; F H Corstens
Journal:  J Clin Oncol       Date:  1992-01       Impact factor: 44.544

3.  Ellman's reagent: 5,5'-dithiobis(2-nitrobenzoic acid)--a reexamination.

Authors:  P W Riddles; R L Blakeley; B Zerner
Journal:  Anal Biochem       Date:  1979-04-01       Impact factor: 3.365

4.  Reduction-mediated technetium-99m labeling of monoclonal antibodies.

Authors:  S J Mather; D Ellison
Journal:  J Nucl Med       Date:  1990-05       Impact factor: 10.057

5.  Equine hepatic and renal metallothioneins. Purification, molecular weight, amino acid composition, and metal content.

Authors:  J H Kägi; S R Himmelhoch; P D Whanger; J L Bethune; B L Vallee
Journal:  J Biol Chem       Date:  1974-06-10       Impact factor: 5.157

6.  111In-labeled nonspecific immunoglobulin scanning in the detection of focal infection.

Authors:  R H Rubin; A J Fischman; R J Callahan; B A Khaw; F Keech; M Ahmad; R Wilkinson; H W Strauss
Journal:  N Engl J Med       Date:  1989-10-05       Impact factor: 91.245

7.  Detection of acute inflammation with 111In-labeled nonspecific polyclonal IgG.

Authors:  A J Fischman; R H Rubin; B A Khaw; R J Callahan; R Wilkinson; F Keech; M Nedelman; S Dragotakes; P B Kramer; G M LaMuraglia
Journal:  Semin Nucl Med       Date:  1988-10       Impact factor: 4.446

8.  The stability of 99Tcm directly labelled to an Fab' antibody via stannous ion and mercaptoethanol reduction.

Authors:  G Mardirossian; C Wu; M Rusckowski; D J Hnatowich
Journal:  Nucl Med Commun       Date:  1992-07       Impact factor: 1.690

9.  Utility of the indium 111-labeled human immunoglobulin G scan for the detection of focal vascular graft infection.

Authors:  G M LaMuraglia; A J Fischman; H W Strauss; F Keech; R Wilkinson; R J Callahan; B A Khaw; R H Rubin
Journal:  J Vasc Surg       Date:  1989-07       Impact factor: 4.268

10.  Preparation of hydrazino-modified proteins and their use for the synthesis of 99mTc-protein conjugates.

Authors:  D A Schwartz; M J Abrams; M M Hauser; F E Gaul; S K Larsen; D Rauh; J A Zubieta
Journal:  Bioconjug Chem       Date:  1991 Sep-Oct       Impact factor: 4.774

View more
  3 in total

Review 1.  Labeling biomolecules with radiorhenium: a review of the bifunctional chelators.

Authors:  Guozheng Liu; Donald J Hnatowich
Journal:  Anticancer Agents Med Chem       Date:  2007-05       Impact factor: 2.505

2.  In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.

Authors:  L E Stearne; I C Gyssens; W H Goessens; J W Mouton; W J Oyen; J W van der Meer; H A Verbrugh
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

3.  Retention of technetium-99m in infectious foci in rats after release from technetium-99m labelled human non-specific polyclonal immunoglobulin G: a dual-label study with hydrazinonicotinamido and iminothiolano immunoglobulin.

Authors:  R A Claessens; E B Koenders; W J Oyen; F H Corstens
Journal:  Eur J Nucl Med       Date:  1996-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.